Biogen Beats Q1 Sales Expectations
This is a news story, published by Investor's Business Daily, that relates primarily to Tecfidera news.
Tecfidera news
For more Tecfidera news, you can click here:
more Tecfidera newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Biosimilar sales. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Biogen stock news, biotech company news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
multiple sclerosis drug salesInvestor's Business Daily
•Health
Health
Biogen beats first-quarter expectations, but shares are down in premarket action

82% Informative
Biogen beat Wall Street expectations for first-quarter sales.
Leqembi and Skyclarys brought in $124 million in sales, growing almost 59% year over year .
Sales of key MS drugs Tysabri and Tecfidera beat expectations.
Biogen cut its earnings expectations to $ 14.50 to $ 15.50 per share.
VR Score
89
Informative language
95
Neutral language
72
Article tone
formal
Language
English
Language complexity
41
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
5
Source diversity
3
Affiliate links
no affiliate links